Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1209-1216

  Ishikawa, Kazunobu ^a   Navab, Mohamad ^a   Leitinger, Norbert ^a   Fogelman, Alan M ^a   Lusis, Aidons J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Bilirubin; Biliverdin; Coculture; Gene expression

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; BILIRUBIN; BILIVERDIN; HEME OXYGENASE; HEMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PROTOPORPHYRIN TIN;

ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID OXIDATION; MONOCYTE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0030930697     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119634     Document Type: Article

References (63)

1. Tenhunen, R., H.S. Marver, and R. Schmid. 1969. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem 244:6388-6394.
2. Shibahara, S., R.M. Muller, and H. Taguchi. 1987. Transcriptional control of rat heme oxygenase by heat shock. J. Biol. Chem. 262:12889-12892.
3. Cruse, I., and M.D. Maines. 1988. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J. Biol. Chem. 263:3348-3353.
4. Maines, M.D. 1988. Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical application. FASEB (Fed. Am. Soc. Exp. Biol.) J. 2: 2557-2568.
5. Taketani, S., H. Kohno, T. Yoshinaga, and R. Tokunaga. 1989. The human 32-kDa stress protein induced by exposure to arsenite and cadmium ions is heme oxygenase. FEBS (Fed. Eur. Biochem. Soc.) Lett. 245:173-176.
6. Keyse, S.M., and R.M. Tyrrell. 1989. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UV radiation, hydrogen peroxide and sodium arsenite. Proc. Natl. Acad. Sci. USA. 86:99-103.
7. Kutty, R.K., C.N. Nagineni, G. Kutty, J.J. Hooks, G.J. Chader, and B. Wiggert. 1994. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J. Cell. Physiol. 159: 371-378.
8. Cantoni, L., C. Rossi, M. Rizzardini, M. Gadina, and P. Ghezzi. 1991. Interleukin-1 and tumor necrosis factor induce hepatic haem oxygenase. Biochem. J. 279:891-894.
9. Morita, T., M.A. Perrella, M. Lee, and S. Kourembanas. 1995. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. USA. 92:1475-1479.
10. Lee, P.J., J. Alam, S.L. Sylvester, N. Inamdar, L. Otterbein, and A.M.K. Choi. 1996. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am. J. Respir. Cell Mol. Biol. 14:556-568.
11. Yoshida, T., P. Biro, T. Cohen, R.M. Muller, and S. Shibahara. 1988. Human heme oxygenase cDNA and induction of its mRNA by heme. Eur. J. Biochem. 171:457-461.
12. Noguchi, M., T. Yoshida, and G. Kikuchi. 1983. A stoichiometric study of heme degradation catalyzed by the reconstituted heme oxygenase system with special consideration of the production of hydrogen peroxide during the reaction. J. Biochem. (Tokyo). 93:1027-1036.
13. Balla, G., G.M. Vercellotti, U. Muller-Eberhard, J. Eaton, and H.S. Jacob. 1991. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab. Invest. 64:648-655.
14. Balla, J., H.S. Jacob, S. Balla, K. Nath, J.W. Eaton, and G.M. Vercellotti. 1993. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. USA. 90:9285-9289.
15. Balla, G., H.S. Jacob, J. Balla, M. Rosenberg, K. Nath, F. Apple, J.W. Eaton, and G.M. Vercellotti. 1992. Ferritin: a cytoprotective antioxidant stratagem of endothelium. J. Biol. Chem. 267:18148-18153.
16. Fakhrai, H., and M.D. Maines. 1992. Expression and characterization of a cDNA for rat kidney biliverdin reductase. Evidence suggesting the liver and kidney enzymes are the same transcript product. J. Biol. Chem. 267:4023-4029.
17. Abraham, N.G., Y. Lavrovsky, M.L. Schwartzman, R.A. Stoltz, R.D. Levere, M.E. Gerritsen, S. Shibahara, and A. Kappas. 1995. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc. Natl. Acad. Sci. USA. 92:6798-6802.
18. Vogt, B.A., J. Alam, A.J. Croatt, G.M. Vercellotti, and K.A. Nath. 1995. Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Lab. Invest. 72:474-483.
19. Lee, P.J., J. Alam, G.W. Wiegand, and A.M.K. Choi. 1996. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc. Natl. Acad. Sci. USA. 93:10393-10398.
20. Otterbein, L., S.L. Sylvester, and A.M.K. Choi. 1995. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am. J. Respir. Cell Mol. Biol. 13:595-601.
21. Stocker, R., Y. Yamamoto, A.F. McDonagh, A.N. Glazer, and B.N. Ames. 1987. Bilirubin is an antioxidant of possible physiological importance. Science (Wash. DC). 235:1043-1046.
22. Neuzil, J., and R. Stocker. 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269:16712-16719.
23. Wu, T.-W., K.-P. Fung, and C.-C. Yang. 1994. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than trolox. Life Sci. 54:477-481.
24. Hulea, S.A., E. Wasowicz, and F.A. Kummerow. 1995. Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin. Biochim. Biophys. Acta. 1259:29-38.
25. Verma, A., D.J. Hirsch, C.E. Glatt, G.V. Ronnett, and S.H. Snyder. 1993. Carbon monoxide: a putative neural messenger. Science (Wash. DC). 259: 381-384.
26. Zakhary, R., S.P. Gine, J.L. Dinerman, M. Ruat, N.A. Flavahan, and S.H. Snyder. 1996. Heme oxygenase-2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc. Natl. Acad. Sci. USA. 93: 795-798.
27. Suematsu, M., S. Kashiwagi, T. Sano, N. Goda, Y. Shinoda, and Y. Ishimura. 1994. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem. Biophys. Res. Commun. 205:1333-1337.
28. Johnson, R.A., M. Lavesa, B. Askari, N.G. Abraham, and A. Nasjletti. 1995. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension (Dallas). 25:166-169.
29. Christodoulides, N., W. Durante, M.H. Kroll, and A.I. Schafer. 1995. Vascular smooth muscle cell heme oxygenases generate guanyl cyclase-stimulatory carbon monoxide. Circulation. 91:2306-2309.
30. Steinberg, D., S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum. 1989. Beyond cholesterol. Modifications of low density lipoproteins that increase its atherogenicity. N. Engl. J. Med. 320:915-924.
31. Witztum, J.L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
32. Morel, D.W., P.E. DiCorleto, and G.M. Chisolm. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:357-364.
33. Steinbrecher, U.P., S. Parthasarathy, D.S. Leake, J.L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:3883-3887.
34. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
35. Berliner, J.A., and J.W. Heinecke. 1996. The role of oxidized lipoproteins in atherosclerosis. Free Radical Biol. Med. 20:707-727.
36. Sasahara, M., E.W. Raines, A. Chait, T.E. Carew, D. Steinberg, P.W. Wahl, and R. Ross. 1994. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. J. Clin. Invest. 94:155-164.
37. Williams, R.J., J.M. Motteram, C.H. Sharp, and P.J. Gallagher. 1992. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis. 94:153-159.
38. Siow, R.C.M., T. Ishii, H. Sato, S. Taketani, D.S. Leake, J.H. Sweiry, J.D. Peason, S. Bannai, and G.E. Mann. 1995. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidized LDL in cultured vascular smooth muscle cells. FEBS (Fed. Eur. Biochem. Soc.) Lett. 368:239-242.
39. Agarwal, A., J. Balla, G. Balla, A.J. Croatt, G.M. Vercellotti, and K.A. Nath. 1996. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am. J. Physiol. 271:F814-F823.
40. Zhu, W., P. Roma, A. Pirillo, F. Pellegatta, and A.L. Catapano. 1996. Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating. Arterioscler. Thromb. Vasc. Biol. 16:1104-1111.
41. Tsukamoto, Y., K. Kuwabara, S. Hirota, J. Ikeda, D. Stern, H. Yanagi, M. Matsumoto, S. Ogawa, and Y. Kitamura. 1996. 150-kD oxygen-regulated protein is expressed in human atherosclerotic plaque and allows mononuclear phagocytes to withstand cellular stress on exposure hypoxia and modified low density lipoprotein. J. Clin. Invest. 98:1930-1941.
42. Navab, M., S.S. Imes, S.Y. Hama, G.P. Hough, L.A. Ross, R.W. Bork, A.J. Valente, J.A. Berliner, D.C. Drinkwater, H. Laks, and A.M. Fogelman. 1991. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88:2039-2046.
43. Navab, M., G.P. Hough, L.W. Stevenson, D.C. Drinkwater, H. Laks, and A.M. Fogelman. 1988. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J. Clin. Invest. 82:1853-1863.
44. Cushing, S.D., J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab, F. Parhami, R. Gerrity, C.J. Schwartz, and A.M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:5134-5138.
45. Quinn, M.T., S. Parthasarathy, L.G. Fong, and D. Steinberg. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophage during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:2995-2998.
46. Havel, R.J., E.A. Eder, and J.H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins of human serum. J. Clin. Invest. 43:1345-1353.
47. Berliner, J.A., M.C. Territo, A. Sevanian, S. Ramin, J.A. Kim, B. Bamshad, M. Esterson, and A.M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
48. Watson, A.D., M. Navab, S.Y. Hama, A. Sevanian, S.M. Prescott, D.M. Stafforini, T.M. McIntyre, B.N. La Du, A.M. Fogelman, and J.A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95:774-782.
49. Watson, A.D., J.A. Berliner, S.Y. Hama, B.N. La Du, K.F. Faull, A.M. Fogelman, and M. Navab. 1995. Protective effect of high density lipoprotein associated paraoxonase. J. Clin. Invest. 96:2882-2891.
50. Watson, A.D., N. Leitinger, M. Navab, K.F. Faull, S. Hörkkö, J.L. Witztum, W. Palinski, D. Schwenke, R.G. Salomon, W. Sha, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272:13597-13607.
51. Fogelman, A.M., K. Sykes, B.J. Van Lenten, M.C. Territo, and J.A. Berliner. 1988. Modification of the Recalde method for the isolation of human monocyte. J. Lipid Res. 29:1243-1247.
52. Ishikawa, K., M. Sato, and T. Yoshida. 1991. Expression of rat heme oxygenate in Escherichia coli as a catalytically active, full-length form that binds to bacterial membranes. Eur. J. Biochem. 202:161-165.
53. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
54. Navab, M., S.Y. Hama, B.J. Van Lenten, D.C. Drinkwater, H. Laks, and A.M. Fogelman. 1993. A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells. J. Clin. Invest. 91:1225-1230.
55. Alam, J., J. Cai, and A. Smith. 1994. Isolation and characterization of the mouse heme oxygenase-1 gene: distal 5′ sequences are required for induction by heme or heavy metals. J. Biol. Chem. 269:1001-1009.
56. Alam, J., and Z. Den. 1992. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J. Biol. Chem. 267:21894-21900.
57. Lavrovsky, Y., M.L. Schwartzman, R.D. Levere, A. Kappas, and N.G. Abraham. 1994. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. USA. 91:5987-5991.
58. Inamdar, N.M., Y.I. Ahn, and J. Alam. 1996. The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem. Biophys. Res. Commun. 221:570-576.
59. Morita, T., and S. Kourembanas. 1995. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J. Clin. Invest. 96:2676-2682.
60. Liao, F., A. Andalibi, F.C. deBeer, A.M. Fogelman, and A.J. Lusis. 1993. Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91:2572-2579.
61. Frei, B., R. Stocker, and B.N. Ames. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85:9748-9752.
62. Schwertner, H.A., W.G. Jackson, and G. Tolan. 1994. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin. Chem. 40:18-23.
63. Hopkins, P.N., L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams. 1996. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16:250-255.